Teladoc Health, Inc. (TDOC) All Metrics
TDOC Valuation Metrics
TDOC Stock Price Metrics
TDOC Dividend Metrics
TDOC Growth Rate Metrics
TDOC Discounted Cash Flow Metrics
| Fair Value Price | $17.14 |
| Margin of Safety | 126.11% |
TDOC Revenue Metrics
TDOC PE Ratio Metrics
| PE Ratio | - |
| PE Ratio Avg TTM | - |
| PE Ratio Avg 3Y | - |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | - |
TDOC PS Ratio Metrics
| PS Ratio | 0.54 |
| PS Ratio Avg TTM | 0.49 |
| PS Ratio Avg 3Y | 0.73 |
| Current VS TTM Avg | +11.07% |
| Current VS 3Y Avg | -26.10% |
| Current VS 5Y Avg | -52.66% |
TDOC PB Ratio Metrics
| PB Ratio | 1.02 |
| PB Ratio Avg TTM | 0.88 |
| PB Ratio Avg 3Y | 1.03 |
| Current VS TTM Avg | +15.60% |
| Current VS 3Y Avg | -1.13% |
| Current VS 5Y Avg | -3.03% |
TDOC Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 5.41 |
| PFCF Ratio Avg TTM | 5.78 |
| PFCF Ratio Avg 3Y | 6.12 |
| Current VS TTM Avg | -6.37% |
| Current VS 3Y Avg | -11.62% |
| Current VS 5Y Avg | -57.29% |
TDOC Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.75 |
| Debt/Equity Ratio Avg TTM | 0.91 |
| Debt/Equity Ratio Avg 3Y | 0.80 |
| Current VS TTM Avg | -17.13% |
| Current VS 3Y Avg | -5.66% |
| Current VS 5Y Avg | +34.33% |
TDOC PEG Ratio Metrics
| PEG Ratio | - |
| PEG Ratio Avg TTM | - |
| PEG Ratio Avg 3Y | 0.12 |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | - |
TDOC FCF Yield
| FCF Yield | 18.48% |
| FCF Yield Avg TTM | 18.05% |
| FCF Yield Avg 3Y | 15.18% |
| Current VS TTM Avg | +2.36% |
| Current VS 3Y Avg | +21.77% |
| Current VS 5Y Avg | +57.58% |
TDOC Earnings Yield
| Earnings Yield | (16.24%) |
| Earnings Yield Avg TTM | (40.41%) |
| Earnings Yield Avg 3Y | (111.21%) |
| Current VS TTM Avg | -59.81% |
| Current VS 3Y Avg | -85.40% |
| Current VS 5Y Avg | -78.37% |
TDOC EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | (5.68) |
| Ev/Ebit Ratio Avg TTM | (3.74) |
| Ev/Ebit Ratio Avg 3Y | (5.94) |
| Current VS TTM Avg | +51.87% |
| Current VS 3Y Avg | -4.38% |
| Current VS 5Y Avg | -70.79% |
TDOC EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 28.70 |
| Ev/Ebitda Ratio Avg TTM | 81.93 |
| Ev/Ebitda Ratio Avg 3Y | 69.31 |
| Current VS TTM Avg | -64.97% |
| Current VS 3Y Avg | -58.59% |
| Current VS 5Y Avg | -58.59% |
TDOC EV/Assets Ratio Metrics
| Ev/Assets Ratio | 0.59 |
| Ev/Assets Ratio Avg TTM | 0.52 |
| Ev/Assets Ratio Avg 3Y | 0.59 |
| Current VS TTM Avg | +12.62% |
| Current VS 3Y Avg | +0.69% |
| Current VS 5Y Avg | -17.19% |
TDOC EV/Sales Ratio Metrics
| Ev/Sales Ratio | 0.65 |
| Ev/Sales Ratio Avg TTM | 0.61 |
| Ev/Sales Ratio Avg 3Y | 0.88 |
| Current VS TTM Avg | +6.15% |
| Current VS 3Y Avg | -26.46% |
| Current VS 5Y Avg | -52.76% |
TDOC Current Ratio Metrics
| Current Ratio | 2.69 |
| Current Ratio Avg TTM | 2.23 |
| Current Ratio Avg 3Y | 2.80 |
| Current VS TTM Avg | +20.63% |
| Current VS 3Y Avg | -4.10% |
| Current VS 5Y Avg | -10.88% |
TDOC Quick Ratio Metrics
| Quick Ratio | 2.59 |
| Quick Ratio Avg TTM | 2.16 |
| Quick Ratio Avg 3Y | 2.71 |
| Current VS TTM Avg | +19.91% |
| Current VS 3Y Avg | -4.60% |
| Current VS 5Y Avg | -10.48% |
TDOC ROIC Metrics
| ROIC | (8.26%) |
| ROIC Avg 3Y | (90.85%) |
| ROIC Avg 5Y | (61.23%) |
| Current VS 3Y Avg | -90.91% |
| Current VS 5Y Avg | -86.51% |
| Current VS 10Y Avg | -79.10% |
TDOC Return on Assets Metrics
| ROA | (6.46) |
| ROA Avg TTM | (17.46) |
| ROA Avg 3Y | (82.63) |
| Current VS TTM Avg | -63.01% |
| Current VS 3Y Avg | -92.18% |
| Current VS 5Y Avg | -88.45% |
TDOC Return on Equity Metrics
| ROE | (14.46) |
| ROE Avg TTM | (40.81) |
| ROE Avg 3Y | (170.75) |
| Current VS TTM Avg | -64.56% |
| Current VS 3Y Avg | -91.53% |
| Current VS 5Y Avg | -87.40% |
TDOC Net Profit Margin Metrics
| Net Profit Margin | (7.92%) |
| Net Profit Margin Avg TTM | (23.45%) |
| Net Profit Margin Avg 3Y | (155.72%) |
| Current VS TTM Avg | -66.22% |
| Current VS 3Y Avg | -94.91% |
| Current VS 5Y Avg | -93.10% |
Last Updated: Tuesday, June 23, 2026
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita